Realpage RP 深 沪
等待开盘
--
0.000
NaN.00%
华盛通- 最 高--
- 今 开--
- 成交量 --
- 最 低 --
- 昨 收 --
- 总市值 0
- 52周最高 --
- 市盈率 静 0.00
- 换手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 总股本 0.00亿
- 历史最高 --
- 量 比 0
- 振 幅 NaN.00%
- 历史最低 --
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多What's Going On With Sandisk Stock Thursday?
Sandisk (SNDK) rose over 1% premarket to $1,763.61, backed by strong NAND flash demand, AI growth, and Micron's upbeat results.
10-01 19:00
Sandisk Dips Premarket on Market Weakness, But Multi-Year AI Storage Outlook Remains Intact
Sandisk stock slips premarket despite strong AI inference demand as management highlights long-term cloud agreements and robust technical trendlines.
09-24 20:39
Sandisk Stock Extends Losses As AI Memory Trade Unravels
Sandisk (SNDK) stock drops in premarket trading as AI memory shares sell off. Read key technical levels and Q4 earnings expectations.
07-28 18:49
What's Going on With Sandisk Stock Monday?
SanDisk (SNDK) stock jumped 4%+ premarket as chip stocks rally ahead of Aug. 5 earnings. Key technical levels & analyst outlook inside.
07-27 19:05
Why Is Sandisk Stock Falling Friday?
SanDisk stock (SNDK) drops 5% premarket as traders lock in profits following Thursday's massive AI-driven memory chip rally.
06-26 20:24
Dow Taps Veteran Insider Karen Carter As CEO
Dow names Karen S. Carter as new CEO effective July 1, 2026. Jim Fitterling moves to Executive Chair. Get the full leadership update.
04-14 20:03
What's Going On With Sandisk Shares on Monday?
Sandisk shares rise premarket after the company announced it will join the Nasdaq-100 Index on April 20, replacing Atlassian.
04-13 19:19
Centene (CNC) Stock Slides After Medicare Advantage Update
Centene shares are trading sharply lower Tuesday morning after federal regulators outlined 2027 Medicare Advantage payment changes that amounted to effectively flat funding for insurers.
01-27 23:39
新闻纵深·县域特色产业新力量｜牵手知名车企，零部件制造换挡升级
（来源：河北新闻网） 转自：河北新闻网 阅读提示 你也许不知道，你的爱车车门上的密封条、车上的空调滤芯，很可能产自清河。 如今，清河汽车零部件集群与长安、吉利...
2025-10-24 07:34
宜明昂科-B(01541)：IMM2510联合IMM01的IB/II期临床试验完成首例患者给药
宜明昂科-B(01541)发布公告，IMM2510联合IMM01治疗晚期实体瘤的IB/II期临床试验顺利完成首例患者给药，标志着本集团在创新癌症免疫治疗领域取得...
2025-10-23 16:51
